Shares of Moderna surged 9.5% on Tuesday to $32.75 in a notable reversal of recent bearish sentiment, buoyed by legal developments and renewed investor focus on the company’s potential vaccine pipeline. The uptick follows a turbulent period for the pharmaceutical firm, which has seen its stock tumble more than 80%…
SovEcon, a prominent agricultural consultancy, has significantly increased its projection for Russian wheat exports for the 2025-26 marketing season. The…
Around 2,300 individuals succumbed to heat-related illnesses across 12 European cities during the intense heatwave that concluded last week,…
China’s ongoing policy efforts to curb excess industrial capacity could serve as a significant positive catalyst for both its…
European stock markets started Wednesday’s session with modest gains, as investors carefully navigated a complex and often contradictory global…
Starbucks is exploring a potential partial sale of its China operations, with offers from global and Asia-based private equity…
Shares in French-Italian eyewear giant EssilorLuxottica jumped more than 5% to €251.70 on Tuesday after reports emerged that Meta…
Elon Musk, the billionaire chief executive of Tesla Inc (NASDAQ: TSLA) has officially launched a new political movement –…